Evolution of Plasmodium falciparum antimalarial drug resistance markers post-adoption of artemisinin-based combination therapies in Yaounde, Cameroon
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The widespread PfMDR1 NFSND haplotype (93.0%), consistent with reports from Ethiopia35,36,53 and across Africa54,55, further complicates resistance dynamics.”
From Genomic surveillance reveals co-occurrence of Plasmodium falciparum drug resistance variants across diverse transmission settings in Ethiopia (2026) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug-Resistant Malaria: The Era of ACT
Lin, J. T., Juliano, J. J., & Wongsrichanalai, C. (2010) · Current Infectious Disease Reports · doi:10.1007/s11908-010-0099-y · Cited by 121 · cited 2×
“This could lead to a resurgence of malaria cases if he resistance to ACTs reported initially in Southeast Asia spreads o Africa, as was the case with CQ and SP resistance [6] .”
Background
Research works printed but not linked: 26
- Pearce RJ Pota H Evehe MSB Bâ EH Mombo-Ngoma G Malisa AL Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria PLoS Med 6 2009 e1000055 10.1371/journal.pmed.1000055 PMC2661256 19365539 · DOI · Paper page
- Uwimana A Legrand E Stokes BH Ndikumana JM Warsame M Umulisa N Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda Nat Med 26 2020 1602 1608 10.1038/s41591-020-1005-2 32747827 PMC7541349 · DOI · Paper page
- Ndwiga L Kimenyi KM Wamae K Osoti V Akinyi M Omedo I A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa Int J Parasitol Drugs Drug Resist 16 2021 155 161 10.1016/j.ijpddr.2021.06.001 34146993 PMC8219943 · DOI
- Malmberg M Ngasala B Ferreira PE Larsson E Jovel I Hjalmarsson A Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district Tanzania. Malar J 12 2013 103 10.1186/1475-2875-12-103 23506218 PMC3732084 · DOI
- Nag S Dalgaard MD Kofoed PE Ursing J Crespo M Andersen LO High throughput resistance profiling of Plasmodium falciparum infections based on custom dual indexing and Illumina next generation sequencing-technology Sci Rep 7 2017 2398 10.1038/s41598-017-02724-x 28546554 PMC5445084 · DOI
- Nag S Ursing J Rodrigues A Crespo M Krogsgaard C Lund O Proof of concept: used malaria rapid diagnostic tests applied for parallel sequencing for surveillance of molecular markers of anti-malarial resistance in Bissau, Guinea-Bissau during 2014–2017 Malar J 18 2019 252 10.1186/s12936-019-2894-8 31349834 PMC6660714 · doi:10.1186/s12936-019-2894-8
- Niba PTN Nji AM Evehe MS Ali IM Netongo PM Ngwafor R Drug resistance markers within an evolving efficacy of anti-malarial drugs in Cameroon: a systematic review and meta-analysis (1998–2020) Malar J 20 2021 32 10.1186/s12936-020-03543-8 33422080 PMC7796563 · DOI
- Moyeh MN Njimoh DL Evehe MS Ali IM Nji AM Nkafu DN Effects of drug policy changes on evolution of molecular markers of Plasmodium falciparum resistance to chloroquine, amodiaquine, and sulphadoxine-pyrimethamine in the south west region of Cameroon Malar Res Treat 2018 2018 7071383 10.1155/2018/7071383 PMC5954917 29854394 · DOI
- WWARN K13 Genotype-Phenotype Study Group Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments-a WWARN individual patient data meta-analysis BMC Med 17 2019 1 10.1186/s12916-018-1207-3 30651111 PMC6335805 · DOI · Paper page
- Egwu CO Obasi NA Aloke C Nwafor J Tsamesidis I Chukwu J Impact of drug pressure versus limited access to drug in malaria control: the dilemma Medicines (Basel) 9 2022 2 10.3390/medicines9010002 35049935 PMC8779401 · DOI
- Hemming-Schroeder E Umukoro E Lo E Fung B Tomás-Domingo P Zhou G Impacts of antimalarial drugs on Plasmodium falciparum Drug resistance markers, Western Kenya, 2003–2015 Am J Trop Med Hyg 98 2018 692 699 10.4269/ajtmh.17-0763 29363453 PMC5930917 · DOI
- Antonio-Nkondjio C Ndo C Njiokou F Bigoga JD Awono-Ambene P Etang J Review of malaria situation in Cameroon: technical viewpoint on challenges and prospects for disease elimination Parasit Vectors 12 2019 501 10.1186/s13071-019-3753-8 31655608 PMC6815446 · DOI · Paper page
- Achonduh-Atijegbe OA Mfuh KO Mbange AHE Chedjou JP Taylor DW Nerurkar VR Prevalence of malaria, typhoid, toxoplasmosis and rubella among febrile children in Cameroon BMC Infect Dis 16 2016 658 10.1186/s12879-016-1996-y 27825318 PMC5101675 · DOI
- Mbacham WF Evehe MSB Netongo PM Ateh IA Mimche PN Ajua A Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy Malar J 9 2010 34 10.1186/1475-2875-9-34 20105282 PMC2831903 · DOI
- Niba PTN Nji AM Ali IM Akam LF Dongmo CH Chedjou JPK Effectiveness and safety of artesunate–amodiaquine versus artemether–lumefantrine for home-based treatment of uncomplicated Plasmodium falciparum malaria among children 6–120 months in Yaoundé, Cameroon: a randomized trial BMC Infect Dis 22 2022 166 10.1186/s12879-022-07101-2 35189818 PMC8862275 · DOI
- Plowe CV Djimde A Bouare M Doumbo O Wellems TE. Pyrimethamine and Proguanil resistance-conferring mutations in Plasmodium falciparum Dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa Am J Trop Med Hyg 52 1995 565 568 10.4269/ajtmh.1995.52.565 7611566 · DOI · Paper page
- Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads EMBnet J 17 2011 10 10.14806/ej.17.1.200 · DOI · Paper page
- Leekitcharoenphon P Nielsen EM Kaas RS Lund O Aarestrup FM. Evaluation of whole genome sequencing for outbreak detection of Salmonella enterica PLoS One 9 2014 e87991 10.1371/journal.pone.0087991 24505344 PMC3913712 · DOI · Paper page
- L'Episcopia M Kelley J Djeunang Dongho BG Patel D Schmedes S Ravishankar S Targeted deep amplicon sequencing of antimalarial resistance markers in Plasmodium falciparum isolates from Cameroon Int J Infect Dis 107 2021 234 241 10.1016/j.ijid.2021.04.081 33940188 · DOI
- Apinjoh TO Mugri RN Miotto O Chi HF Tata RB Anchang-Kimbi JK Molecular markers for artemisinin and partner drug resistance in natural Plasmodium falciparum populations following increased insecticide treated net coverage along the slope of Mount Cameroon: cross-sectional study Infect Dis Poverty 6 2017 136 10.1186/s40249-017-0350-y 29110722 PMC5674235 · DOI
- Otienoburu SD Maïga-Ascofaré O Schramm B Jullien V Jones JJ Zolia YM Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia Malar J 15 2016 452 10.1186/s12936-016-1503-3 27596849 PMC5011943 · doi:10.1186/s12936-016-1503-3
- Sutherland CJ Fifer H Pearce RJ bin Reza F Nicholas M Haustein T Novel Pfdhps haplotypes among imported cases of Plasmodium falciparum malaria in the United Kingdom Antimicrob Agents Chemother 53 2009 3405 3410 10.1128/AAC.00024-09 19433569 PMC2715629 · DOI
- Oguike MC Falade CO Shu E Enato IG Watila I Baba ES Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V Int J Parasitol Drugs Drug Resist 6 2016 220 229 10.1016/j.ijpddr.2016.08.004 27821281 PMC5094156 · DOI
- Tuedom AGB Sarah-Matio EM Moukoko CEE Feufack-Donfack BL Maffo CN Bayibeki AN Antimalarial drug resistance in the Central and Adamawa regions of Cameroon: prevalence of mutations in P. falciparum crt, Pfmdr1, Pfdhfr and Pfdhps genes PLoS One 16 2021 e0256343 10.1371/journal.pone.0256343 PMC8376100 34411157 · DOI
- Beshir KB Muwanguzi J Nader J Mansukhani R Traore A Gamougam K Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine–pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance study Lancet Infect Dis 23 2023 361 370 10.1016/S1473-3099(22)00593-X 36328000 · DOI
- Matondo SI Temba GS Kavishe AA Kauki JS Kalinga A van Zwetselaar M High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in Tanzania Malar J 13 2014 152 10.1186/1475-2875-13-152 24751352 PMC3998221 · DOI
Cited by
Letebo, A., Vanheer, L. N., Engdaw, M., Ejigu, L. A., Hailu Alemayehu, D., Deressa, J. D., Adnew, B., Ayele, A., Bezabih, M. K., Demisse, M., et al. (2026) · Nature Microbiology · doi:10.1038/s41564-026-02420-5 · Cited by 4
Metadata
- Authors
- Niba, P. T. N., Nji, A. M., Chedjou, J. P. K., Hansson, H., Hocke, E. F., Ali, I. M., Achonduh-Atijegbe, O., Evehe, M.-S. B., Jørgensen, M. H. M., Fomboh, C. T., Cui, L., Stresman, G., Bigoga, J. D., Alifrangis, M., & Mbacham, W. F.
- Venue
- International Journal of Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2023-07
- Volume
- 132
- Pages
- 108-117
- ISSN
- 1201-9712
- PMC
- PMC10182900
- Cited by
- 24
- References
- 1
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- Wellcome Trust
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evolution of Plasmodium falciparum antimalarial drug resistance markers post-adoption of artemisinin-based combination therapies in Yaounde, Cameroon. https://app.cochat.ai/papers/10.1016/j.ijid.2023.03.050
- The paper
- Niba, P. T. N., Nji, A. M., Chedjou, J. P. K., Hansson, H., Hocke, E. F., Ali, I. M., Achonduh-Atijegbe, O., Evehe, M.-S. B., Jørgensen, M. H. M., Fomboh, C. T., Cui, L., Stresman, G., Bigoga, J. D., Alifrangis, M., & Mbacham, W. F. (2023). Evolution of Plasmodium falciparum antimalarial drug resistance markers post-adoption of artemisinin-based combination therapies in Yaounde, Cameroon. International Journal of Infectious Diseases. https://doi.org/10.1016/j.ijid.2023.03.050
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.